Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
BACKGROUND:Patients infected by Plasmodium vivax or Plasmodium ovale suffer repeated clinical attacks without primaquine therapy against latent stages in liver. Primaquine causes seriously threatening acute hemolytic anemia in patients having inherited glucose-6-phosphate dehydrogenase (G6PD) defici...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-02-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | http://europepmc.org/articles/PMC4760930?pdf=render |
| _version_ | 1818586370223898624 |
|---|---|
| author | Ari W Satyagraha Arkasha Sadhewa Rosalie Elvira Iqbal Elyazar Denny Feriandika Ungke Antonjaya Damian Oyong Decy Subekti Ismail E Rozi Gonzalo J Domingo Alida R Harahap J Kevin Baird |
| author_facet | Ari W Satyagraha Arkasha Sadhewa Rosalie Elvira Iqbal Elyazar Denny Feriandika Ungke Antonjaya Damian Oyong Decy Subekti Ismail E Rozi Gonzalo J Domingo Alida R Harahap J Kevin Baird |
| author_sort | Ari W Satyagraha |
| collection | DOAJ |
| description | BACKGROUND:Patients infected by Plasmodium vivax or Plasmodium ovale suffer repeated clinical attacks without primaquine therapy against latent stages in liver. Primaquine causes seriously threatening acute hemolytic anemia in patients having inherited glucose-6-phosphate dehydrogenase (G6PD) deficiency. Access to safe primaquine therapy hinges upon the ability to confirm G6PD normal status. CareStart G6PD, a qualitative G6PD rapid diagnostic test (G6PD RDT) intended for use at point-of-care in impoverished rural settings where most malaria patients live, was evaluated. METHODOLOGY/PRINCIPAL FINDINGS:This device and the standard qualitative fluorescent spot test (FST) were each compared against the quantitative spectrophotometric assay for G6PD activity as the diagnostic gold standard. The assessment occurred at meso-endemic Panenggo Ede in western Sumba Island in eastern Indonesia, where 610 residents provided venous blood. The G6PD RDT and FST qualitative assessments were performed in the field, whereas the quantitative assay was performed in a research laboratory at Jakarta. The median G6PD activity ≥ 5 U/gHb was 9.7 U/gHb and was considered 100% of normal activity. The prevalence of G6PD deficiency by quantitative assessment (<5 U/gHb) was 7.2%. Applying 30% of normal G6PD activity as the cut-off for qualitative testing, the sensitivity, specificity, positive predictive value, and negative predictive value for G6PD RDT versus FST among males were as follows: 100%, 98.7%, 89%, and 100% versus 91.7%, 92%, 55%, and 99%; P = 0.49, 0.001, 0.004, and 0.24, respectively. These values among females were: 83%, 92.7%, 17%, and 99.7% versus 100%, 92%, 18%, and 100%; P = 1.0, 0.89, 1.0 and 1.0, respectively. CONCLUSIONS/SIGNIFICANCE:The overall performance of G6PD RDT, especially 100% negative predictive value, demonstrates suitable safety for G6PD screening prior to administering hemolytic drugs like primaquine and many others. Relatively poor diagnostic performance among females due to mosaic G6PD phenotype is an inherent limitation of any current practical screening methodology. |
| first_indexed | 2024-12-16T08:51:53Z |
| format | Article |
| id | doaj.art-0aab7fdcf104416a92a8ee0b0b0d7efc |
| institution | Directory Open Access Journal |
| issn | 1935-2727 1935-2735 |
| language | English |
| last_indexed | 2024-12-16T08:51:53Z |
| publishDate | 2016-02-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj.art-0aab7fdcf104416a92a8ee0b0b0d7efc2022-12-21T22:37:23ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352016-02-01102e000445710.1371/journal.pntd.0004457Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.Ari W SatyagrahaArkasha SadhewaRosalie ElviraIqbal ElyazarDenny FeriandikaUngke AntonjayaDamian OyongDecy SubektiIsmail E RoziGonzalo J DomingoAlida R HarahapJ Kevin BairdBACKGROUND:Patients infected by Plasmodium vivax or Plasmodium ovale suffer repeated clinical attacks without primaquine therapy against latent stages in liver. Primaquine causes seriously threatening acute hemolytic anemia in patients having inherited glucose-6-phosphate dehydrogenase (G6PD) deficiency. Access to safe primaquine therapy hinges upon the ability to confirm G6PD normal status. CareStart G6PD, a qualitative G6PD rapid diagnostic test (G6PD RDT) intended for use at point-of-care in impoverished rural settings where most malaria patients live, was evaluated. METHODOLOGY/PRINCIPAL FINDINGS:This device and the standard qualitative fluorescent spot test (FST) were each compared against the quantitative spectrophotometric assay for G6PD activity as the diagnostic gold standard. The assessment occurred at meso-endemic Panenggo Ede in western Sumba Island in eastern Indonesia, where 610 residents provided venous blood. The G6PD RDT and FST qualitative assessments were performed in the field, whereas the quantitative assay was performed in a research laboratory at Jakarta. The median G6PD activity ≥ 5 U/gHb was 9.7 U/gHb and was considered 100% of normal activity. The prevalence of G6PD deficiency by quantitative assessment (<5 U/gHb) was 7.2%. Applying 30% of normal G6PD activity as the cut-off for qualitative testing, the sensitivity, specificity, positive predictive value, and negative predictive value for G6PD RDT versus FST among males were as follows: 100%, 98.7%, 89%, and 100% versus 91.7%, 92%, 55%, and 99%; P = 0.49, 0.001, 0.004, and 0.24, respectively. These values among females were: 83%, 92.7%, 17%, and 99.7% versus 100%, 92%, 18%, and 100%; P = 1.0, 0.89, 1.0 and 1.0, respectively. CONCLUSIONS/SIGNIFICANCE:The overall performance of G6PD RDT, especially 100% negative predictive value, demonstrates suitable safety for G6PD screening prior to administering hemolytic drugs like primaquine and many others. Relatively poor diagnostic performance among females due to mosaic G6PD phenotype is an inherent limitation of any current practical screening methodology.http://europepmc.org/articles/PMC4760930?pdf=render |
| spellingShingle | Ari W Satyagraha Arkasha Sadhewa Rosalie Elvira Iqbal Elyazar Denny Feriandika Ungke Antonjaya Damian Oyong Decy Subekti Ismail E Rozi Gonzalo J Domingo Alida R Harahap J Kevin Baird Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. PLoS Neglected Tropical Diseases |
| title | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. |
| title_full | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. |
| title_fullStr | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. |
| title_full_unstemmed | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. |
| title_short | Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. |
| title_sort | assessment of point of care diagnostics for g6pd deficiency in malaria endemic rural eastern indonesia |
| url | http://europepmc.org/articles/PMC4760930?pdf=render |
| work_keys_str_mv | AT ariwsatyagraha assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT arkashasadhewa assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT rosalieelvira assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT iqbalelyazar assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT dennyferiandika assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT ungkeantonjaya assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT damianoyong assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT decysubekti assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT ismailerozi assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT gonzalojdomingo assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT alidarharahap assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia AT jkevinbaird assessmentofpointofcarediagnosticsforg6pddeficiencyinmalariaendemicruraleasternindonesia |